Welcome to the second issue of Addiction Reviews. It has been an especially exciting time to be able to work toward the maturity of this peer-reviewed series on addiction. The series is broadly titled Addiction Reviews to document interest in multiple aspects of this complex field. Yet the goal remains simple and straightforward: to bring together each year some of the very best minds in the field to review the latest ideas and issues at the heart of the best science in the field of addiction.
To get Addiction Reviews 2 for a special offer of 75% off the cover price, purchase the volume online and enter code “NYASD” at checkout.
Introduction to Addiction Reviews 2
George R. Uhl
Preface to Addiction Reviews 2
George F. Koob
Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders
Christian A. Heidbreder and Amy H. Newman
Cocaine-induced neuroadaptations in glutamate transmission: Potential therapeutic targets for craving and addiction
Heath D. Schmidt and R. Christopher Pierce
Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies
David V. Herin, Craig. R. Rush, and John Grabowski
Amphetamine toxicities: Classical and emerging mechanisms
Bryan K. Yamamoto, Anna Moszczynska, and Gary A. Gudelsky
Human immunodeficiency virus-associated neurocognitive disorder: Pathophysiology in relation to drug addiction
Avindra Nath
Synaptic plasticity in the mesolimbic system: Therapeutic implications for substance abuse
Billy T. Chen, F. Woodward Hopf, and Antonello Bonci
Electrophysiological correlates of abused drugs: Relation to natural rewards
Sam A. Deadwyler
Neurochemistry of drug action: Insights from proton magnetic resonance spectroscopic imaging and their relevance to addiction
Stephanie C. Licata and Perry F. Renshaw
Cocaine addiction in mothers: Potential effects on maternal care and infant development
Lane Strathearn and Linda C. Mayes
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment
Vadim Yuferov, Orna Levran, Dmitri Proudnikov, David A. Nielsen, and Mary Jeanne Kreek
Addictions and their familiality in Iceland
Thorarinn Tyrfingsson, Thorgeir E. Thorgeirsson, Frank Geller, Valgerdur Runarsdóttir, Ingunn Hansdóttir, Gyda Bjornsdottir, Anna K. Wiste, Gudrun A. Jonsdottir, Hreinn Stefansson, Jeffrey R. Gulcher, Hogni Oskarsson, Daniel Gudbjartsson, and Kari Stefansson
Transgenic mice in the study of drug addiction and the effects of psychostimulant drugs
Ichiro Sora, BingJin Li, Moe Igari, F. Scott Hall, and Kazutaka Ikeda
Conditioned taste aversion learning: Implications for animal models of drug abuse
Catherine M. Davis and Anthony L. Riley
The strong relationship between bipolar and substance-use disorder: Mechanisms and treatment implications
Alan C. Swann
Shared brain vulnerabilities open the way for nonsubstance addictions: Carving addiction at a new joint?
Joseph Frascella, Marc N. Potenza, Lucy L. Brown, and Anna Rose Childress
Regulation of the dopamine transporter: Aspects relevant to psychostimulant drugs of abuse
Kyle C. Schmitt and Maarten E. A. Reith
Regulator of G protein-signaling proteins and addictive drugs
John Traynor
Novel phenotype issues raised in cross-national epidemiological research on drug dependence
James C. (Jim) Anthony
Office of National Drug Control Policy: A scientist in drug policy in Washington, DC
Bertha K. Madras